Secondary effects and quality of life with chemotherapy: assessing the impact of an osteopathic treatment (multicentric randomized clinical trial)

Author:

Favier N.1,Guinet A. G.1,Nageleisen M.1,Ceccaldi B.2,Pujade-Lauraine E.3,LeFoll Ch.4,Soudain-Pineau M.5,Turlin C.1,Stubbe L.1

Affiliation:

1. Département Recherche de l′Ecole Supérieure d′Ostéopathie de Paris (ESO)

2. Service d′Oncologie, Hôpital du Val de Grâce

3. Service d′Oncologie, Hôpital Hôtel-Dieu

4. Serviced′Oncologie, Hôpital de Lagny

5. Université Reims Champagne Ardennes, Laboratoire d′Analyses des Contraintes Mécaniques DTI

Abstract

The goal of research. The purpose of this work was to assess the effectiveness of osteopathic treatment aimed to improve the quality of life of patients receiving chemotherapy.Materials and methods. The study was conducted by four osteopaths at the oncology departments of four hospitals in Paris region. Patients were randomly divided into two groups. Patients of the first group received osteopathic treatment first, and then a placebo was used. Patients of the second group received the placebo first and then osteopathic treatment. We used a cross-protocol during two consecutive courses of treatment: each patient served as his or her own control. During the treatment stage osteopathic therapy was used; when the patient was control, the osteopathic treatment was imitated. A modified QLQ-C30 questionnaire was used as an evaluation criterion. It was fi lled in three times: before osteopathic treatment (control), after real treatment (treatment) and after simulated treatment (placebo).Results. The study involved 40 patients — 27 women and 13 men. The differences between the treatment and control stages were very highly significant for such criteria as nausea, vomiting and shortness of breath, highly significant for such criteria as fatigue, and significant for such criteria as pain and sleep disturbance. Efficiency was statistically higher compared with placebo for all of these criteria. No differences were found associated with the sequence of real or simulated treatment, as well as with the variability of osteopaths in different centers.Conclusion. The results of this study indicate that osteopathy is a clinically effective method of correction of side effects in patients receiving chemotherapy. These results are interesting enough to suggest that the presence of osteopaths at oncology departments may be useful for cancer patients. Subsequent studies should confirm these results and quantify the effectiveness of osteopathic correction, so that it could be fully integrated into the classical treatment.

Publisher

The Institute of the Osteopathy and Holistic Medicine

Reference29 articles.

1. Ferlay J., Shin Hr., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010; 127 (12): 2893–2917.

2. Belot A., Grosclaude P., Bossard N., Jougla E., Benhamou E. Cancer incidence and mortality in France over the period 1980–2005. Rev. Epidem. Santé Publ. 2008; 56 (3): 159–175.

3. Launoy G. Cancer: les causes de l′augmentation du nombre de casen France. Questions de Santé publ. 2009; 4: 1–4.

4. Institut de veille Sanitaire. http://www.invs.sante.fr/applications/cancers/cancer_1983_2007/default.htm. Consulté le 15/03/ 2012

5. Grosclaude P., Bossard N., Remontet L., Belot A., Arveux P., Bouvier A. M. et al. Survie des patients atteints de cancer en France: étude des registres du réseauFrancim. Paris: Springer-Verlag: 2007. 406 p.

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3